Influenza Medication Market Size (2022-2030) - Sanofi S.A., Lupin Limited, Novartis AG, Vitaris AG and AstraZaneca Plc
11. Oktober 2022 03:07 ET
|
Growth Plus Reports
Pune, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Influenza Medication Market is expected to clock US$ 1510 million by 2030 and to...
Influenza Medication Market Forecast [2019-2026] | Size Is Projected to Reach USD 993.7 Million by 2026, Exhibiting a CAGR of 2.2%
03. Mai 2021 08:52 ET
|
Fortune Business Insights
Pune, India, May 03, 2021 (GLOBE NEWSWIRE) -- The global “influenza medication market” size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period....
Influenza Medication Market to Hit $993.7 Million with 2.2% CAGR by 2026; Large Unmet Needs of Patient Population to Boost Market Growth in Latin America: Fortune Business Insights™
27. Oktober 2020 08:20 ET
|
Fortune Business Insights
Pune, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The global influenza medication market size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing...
Influenza Medication Market to Reach $993.7 Million by 2026; Growing Research into the Changing Nature of the Influenza Virus to Fuel the Market: Fortune Business Insights™
06. Februar 2020 02:44 ET
|
Fortune Business Insights
Pune, Feb. 06, 2020 (GLOBE NEWSWIRE) -- The global Influenza Medication Market size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing...